Posts

Showing posts with the label oncology

EU Joint Clinical Assessment after the first reports: How should companies interpret the findings?

Breaking Barriers: TECELRA Becomes the First Engineered T-Cell Therapy for Solid Tumors

Exploración de las mutaciones de KRAS en oncología: los desafíos y oportunidades - Segunda parte

Exploring KRAS Mutations in Oncology: A Look at the Challenges and Opportunities - Part Two